Introduction {#Sec1}
============

The term mycotoxin refers to a large number of chemically diverse toxic secondary metabolites formed by fungi *imperfecti* growing on agricultural commodities. Contamination of cereals and grains and related products with mycotoxins causes foodand feed-borne intoxications (mycotoxicoses) in man and livestock. In animal husbandry, mycotoxicoses impair animal health, welfare and productivity causing important economic losses \[[@CR1]\]. Moreover, accumulation of mycotoxins in animal tissues may result indirectly in exposure to humans consuming products of animal origin, as demonstrated for aflatoxin B~1~ and its metabolite aflatoxin M~1~ that is excreted with dairy milk \[[@CR2]\]. Among the more than 300 mycotoxins described as yet, aflatoxin B~1~ and the group of fumonisins are the toxins of major concern in tropical and sub-tropical regions. In contrast, in Europe and other parts of the Northern Hemisphere, preharvest contamination with mycotoxins product by various members of the genus *Fusarium*, including deoxynivalenol (DON) (mostly produced by *F. graminearum* and *F. sporotrichoides*) and zearalenone (ZON) (produced by *F. graminearum* and *F. culmorum* among others), are of major concern particularly in pig production, as pigs are particularly sensitive to the adverse effects of these toxins \[[@CR3]\]. DON leads to symptoms like vomiting, diarrhoea, lower weight gain and feed intake, and causes immunosuppression \[[@CR4]\]. ZON exerts remarkable oestrogenic effects and impairs fertility and reproduction in pigs and other farm animals \[[@CR5]\].

To combat animal mycotoxicoses, different physical and chemical methods have been recommended for the detoxification of mycotoxin-contaminated feedstuffs \[[@CR6]--[@CR9]\]. Among them, the use of mycotoxin adsorbents as feed additives is one of the most promising and widely used approaches to reduce the risk for mycotoxicoses in farm animals, and to minimise carry-over of mycotoxins from contaminated feeds into animal-derived products \[[@CR10], [@CR11]\]. Successful adsorption of aflatoxins by different substances, including phyllosilicate minerals, zeolites, activated charcoal, synthetic resins or yeast cell-wall-derived products, has been demonstrated *in vitro* and *in vivo* \[[@CR12]--[@CR17]\]. The efficacy of the compounds to adsorb ZON and DON has been investigated as well, but the results were less encouraging. An efficient adsorption of ZON by certain zeolites, yeast-wall derived products and polymeric adsorbents has been demonstrated *in vitro* \[[@CR12], [@CR18]--[@CR22]\]. *In vivo* experiments, in which the ZON contaminated feed was supplemented with a mineral clay product, showed an improved female reproductive performance in minks, but failed to reduce the signs hyperestrogenicity \[[@CR23]\]. The inclusion of a commercial product containing esterified glucomannan did also not reverse the increase in the uterine weight of female minks exposed to ZON \[[@CR24]\], whereas fibre addition to the diet of rats appeared to decrease the toxicity of ZON \[[@CR25]\]. A quaternary ammonium anion exchange resin, cholestyramine, has been shown to reduce ZON toxicity in the pre-pubertal mouse uterine weight bioassay \[[@CR26]\]. Regarding DON, only *in vitro* adsorption by activated charcoal \[[@CR27], [@CR28]\] and to a lesser extend by yeast-derived products \[[@CR29]\] has been reported. However, in feeding experiments with weaned piglets, Döll et al. (2005) \[[@CR30]\] failed to demonstrate any beneficial effect of a modified aminosilicate product added to a diet that was naturally contaminated with Fusarium toxins, particularly with DON and ZON.

Since the polarity of the β-dicarbonyl group of aflatoxins is considered to play a pivotal role in their chemical adsorption to phyllosilicate clays (HSCAS) \[[@CR31]\], it has been hypothesised that the lower polarity of ZON and DON is the reason for their lower binding affinity to these materials \[[@CR32]\]. Subsequently, chemical modification of phyllosilicate clays with organic cations have been developed to improve ZON or DON adsorption. For example, Lemke et al. (1998) \[[@CR33]\] developed an organophilic montmorillonite able to effectively bind ZON *in vitro*. However, when applied *in vivo* in the mouse uterine weight bioassay, an enhanced toxicity of ZON was observed, presumably due to the surfactant properties of desorbed quaternary ammonia which increased the rate of absorption of ZON \[[@CR34]\]. These findings demonstrate that in the first screening of potential toxin binders, bioassays indicating a potential enhance absorption and toxicity should be included.

In consideration of these findings we developed a test protocol, which includes as a first step a conventional incubation procedure, indicating the binding capacity of new test compounds. As a second step we used specific bioassays, in which the aqueous phase of the incubation mixture was tested for toxin-specific effects in cell cultures.

In these combined assay, 20 different binders, including 6 commercial products, belonging to *the* following chemical classes were tested: smectites \[[@CR35]\], humic substances \[[@CR36], [@CR37]\] and yeast cell-walls \[[@CR38]--[@CR40]\]. Activated charcoal served as reference compound, as it was shown to bind several mycototoxins, including aflatoxins, patulin, fumonisins, ochratoxin A, ZON and DON \[[@CR10], [@CR19]--[@CR21]\]. The practical application of activated charcoal in feedstuffs, however, is restricted due to technical (dust formation and dark colour) and nutritional (adsorption of minerals, vitamins and other nutrients) limitations. The obtained findings were compared with those of commercial products containing various mineral clays, yeast products and plant extracts, as indicated.

Materials and methods {#Sec2}
=====================

Materials {#Sec3}
---------

Three mineral clays (described in Table [1](#Tab1){ref-type="table"}), six humic substances (described in Table [2](#Tab2){ref-type="table"}), four yeast cell-wall derived products, six commercial 'mycotoxin binders' and activated charcoal were obtained from various companies in Europe, Asia and South America. The yeast cell wall-derived products consisted of: natural yeast cell-wall (Yeast1), modified yeast cell-wall (Yeast2), purified β-glucans (Yeast3) and purified mannoproteins (Yeast4). The composition of the commercial products as stated in the commercial brochures was as follows: Product 1: mixture of clay and yeast-cell wall; Product 2: yeast cellwall; Product 3: combination of yeast cell-wall, clay and plant extracts; Product 4: HSCAS (Hydrated Sodium Calcium Aluminum Silicate); Product 5: kaolinite, micaceous mineral, feldspar, quartz and carbonaceous material; and, Product 6: modified HSCAS.

Zearalenone (ZON), deoxynivalenol (DON) and MTT \[(3--4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolim bromide\] were supplied by SIGMA (St. Louis, MO, U.S.A). Alamar blue (AB) was purchased from BioSource International (Camarillo, CA, USA). MCF-7 cells were obtained from (ECACC) European Collection of Cell Culture. Dulbecco's Modified Eagle's Medium (DMEM), phosphate buffered saline (PBS), foetal calf serum (FCS) and [l]{.smallcaps}-glutamine were purchased from Invitrogen (Breda, The Netherlands). All solvents used in chromatography were of HPLC grade; all other reagents were of analytical grade. Table 1Composition of the natural mineral phyllosilicates investigatedSampleCompositionPhysico-chemical properties^a^Dry granulometry (%)C.E.C. (meq/ 100 g)S.A. (m^2^/g)CaCO~3~ (%)Moisture (%)% Water AbsorptionpH Bulk density (g/l)Ash (%)\>125 µm75 µm45 µm\>45 µmMineral1Smectite (93%),45.4604.07.74777.48209.234.812.918.963.5Quartz (5%),Dolomite (1),Feldspar (1%) andtraces of plaster,ilite and kaoliniteMineral2Smectite (95%),144.351215.2419198294.0613.717.121.447.9Quartz (1%),Feldspar (1%)and mica (traces)Mineral3Smectite (96%),41.411427.1812188447.094.516.823.655.2Quartz (1%) andtraces of plaster,ilite and kaolinite^a^ C.E.C. = Cation Exchange Capacity.S.A. = Surface Area.Table 2Composition of the natural humic substances investigatedSampleCompositionPhysico-chemical propertiesDry granulometry (%)Moisture (%)% Water AbsorptionpHBulk density (g/l)\>125 µm75µm45µm\>45µmHumic1Leonardite18.5563.96639.319.526.145.1Humic2Humic substances mixture14.6447.166152.616.512.618.4Humic3Humic substances mixture54.9829.456826.99.818.644.7Humic4Humic substances mixture2.0557.87998.19.019.963.0Humic5Lignosulfonate7.4soluble8.24345.412.548.233.9Humic6Lignosulfonate8.0soluble6.24816.641.528.523.4

Assessment of pH-dependent adsorption {#Sec4}
-------------------------------------

The tested products were suspended in PBS solution (CaCl~2~ × 2H~2~O, 1.2 mM; KCl, 2.7 mM; KH~2~PO~4~, 1.5 mM; MgCl~2~ × 6H~2~O, 1.1 mM; NaCl, 138 mM; Na~2~HPO~4~ × 2H~2~O, 8.1 mM; pH = 6.5) to reach final concentrations of 5, 2.5 or 1 mg of product/ml. Either DON or ZON were added to this suspension at a final concentration of 1 mg/l (1 ppm). Two types of negative controls were included: (1) PBS solution with mycotoxin without adsorbent and (2) PBS solution with adsorbent without mycotoxin. The pH of the mixtures were adjusted to 2.5 with HCl (1 M) and incubated at 37°C for 1 h under constant agitation to simulate the pH conditions during gastric passage in monogastric animal. After this first incubation step, a sample was taken for further analysis. The incubations were continued in the same flask by raising the pH of to pH 8.0 with NaOH (1 M) and leaving the incubation mixture for 3 h under constant agitation at 37°C to simulate the pH conditions during intestinal passage of a monogastric animal. After this time, a second sample was taken. Both samples were immediately filtered (Minisart-GF with a retention efficiency of 98% for 0.7 lm spherical particles; Sartorious, Gottingen, Germany) to separate the binder from the aqueous phase and stored at −20°C until analysis.

DON analysis by HPLC {#Sec5}
--------------------

One millilitre (1 ml) of each filtrated aliquot was cleaned-up using DON inmunoafinity columns (DONtest™ HPLC; VICAM, Watertown, USA). The final methanol effluent was evaporated under a nitrogen stream and the obtained residue redissolved in 250 µl of the mobile phase, of which 50 µl were injected in the HPLC system. HPLC analyses were performed using a AS300 Thermo Separation Products HPLC system (Spectra-Physics, USA). A C18 ChromSpher, stainless steel, 5 lm column (100 × 3.0 mm, Chrompack, The Netherlands) was connected to SpectraSeries P100 Isocratic pumps set at a flow rate of 0.2 ml/min. The mobile phase consisted of acetonitril : water (10:90 v:v). A UV150 detector set at 218 nm and linked to a Data Jet Integrator was used as detection system. The limit of quantification (LOQ) was estimated to be 0.05 mg DON/l.

ZON analysis by HPLC {#Sec6}
--------------------

One and a half millilitres (1.5 ml) of each filtrated aliquot were extracted with 7.5 ml of chloroform. The water phase was discarded and the chloroform evaporated under a nitrogen stream. The obtained residue was re-dissolved in 200 µl of mobile phase from which 50 µl were injected in the HPLC system. A C18 Luna II, stainless steel, 5 lm column (150 × 4.6 mm; Phnomenex, The Netherlands) was connected to two high precision pumps (Gynkotek model 300) set at a flow rate of 0.7 ml/min and controlled by a Chromeleon-Gynkotec HPLC software (Softron). The mobile phase consisted of methanol / water (70:30 v:v). Fluorescence detection was performed with a FP 920 fluorescence detector (Jasco, Japan) set at 236 nm excitation wavelength and 418 nm emission wavelength. The limit of quantification was estimated to be 0.04 mg ZON/l.

Bioassay for the evaluation of trichothecene cytotoxiciy {#Sec7}
--------------------------------------------------------

Various authors have described that trichothecenes exert a typical cytotoxicity (42) and hence an established fibroblast cell line was used to measure the residual bioactivity of DON in the incubation samples. In brief, 5 ml of each filtrated aliquot were lyophilised using a Freezemobile 6 unit (Virtis Company, USA). The residue was re-dissolved in 2 ml of cell culture medium. This consisted of DMEM medium with phenol red supplemented with 10% bovine calf serum, 1% penicillin (100 units/ml), streptomycin (100 µg/ml), 1% [l]{.smallcaps}-glutamine, 1% sodium pyruvate (1 mM). A monolayer culture of NIH/3T3-LNCX, a cell line originating from mouse fibroblasts, was sub-cultured in DMEM medium and incubated at 37°C in a humidified atmosphere containing 5% CO~2~ for 72 to 96 h. After this time, the cells were detached and seeded into 96 well culture plates at a density of 10^4^ cells/well with 200 µl medium/well. After 24 h of incubation, the medium was removed and medium containing the lyophilised residue of the toxin-binder incubations and dilutions thereof were added. Incubation medium without DON was used as control. After 24 h of incubation, the Alamar Blue (AB) reduction assay was performed as previously described \[[@CR41]\]. Briefly, the medium was removed and fresh medium containing AB was added. Following 3 h of incubation, AB was measured fluorometrically at 530 nm (excitation) and 590 nm (emission). Data were expressed as relative absorbance in comparison to parallel incubations conducted with DON at the given concentration without any binding substance.

E-screen bioassay assessing estrogenic activity {#Sec8}
-----------------------------------------------

This bioassay is based on the method of Soto et al. \[[@CR42]\] and detects even small amounts of estrogenic activity associated with residual amounts of ZON and its metabolites. The assay was conducted with minor modifications as described previously \[[@CR43]\]. Briefly, 5 ml of each filtrated aliquot were lyophilised using a Freezemobile 6 unit (Virtis Company, USA). The residue was re-dissolved in 5 ml of the cell culture medium. This consisted of DMEM medium without phenol red supplemented with 10% stripped bovine calf serum (estrogen-free), 1% penicillin (100 units/ml), streptomycin (100 µg/ml), 1% [l]{.smallcaps}-glutamine, 1% sodium pyruvate (100 mM), and 0.1 % bovine insulin (0.001 M). After sterilising by filtration (0.25 µM; Corning, Germany), a 106 dilution of the medium was prepared. A monolayer culture of human breast cancer cells (MCF-7) was sub-cultured in DMEM medium and incubated at 37°C in a humidified atmosphere containing 5% CO~2~ for 72 to 96 h. After this time, the cells were detached and seeded into 96 well culture plates at a density of 10^4^ cells/well with 200 µl medium/well. After 24 h of incubation, the medium was removed and medium containing the lyophilised residue of the toxin binder incubations and dilutions thereof were added. Normal medium was used as control. After 6 days of incubation, the cell proliferation was assessed using the MTT (dimethylthiazol diphenyl tetrazolium bromide) test as described originally by Denizat and Lang (1986) \[[@CR44]\], with minor modifications. Briefly, the medium was discarded and fresh medium containing 0.6 mg MTT/ml was added to the cells. After 3 to 4 h of incubation, the medium was removed and the reaction stopped by adding HCl/Iso-propanol 2:98 (v/v). Formazan, a product formed by the mitochondrial enzyme succinate dehydrogenase in viable cells, was measured at 590 nm. Data were expressed as relative absorbance in comparison to control incubations conducted with ZON at the given concentrations without any binding substance.

Calculation of the DON and ZON adsorption capacity per substance {#Sec9}
----------------------------------------------------------------

Two figures are given to express the DON and ZON adsorption capacity of each adsorbent. Figure [1](#Fig1){ref-type="fig"}, called acidic adsorption (Ac), is based on the analyses of the aliquots taken after the first incubation at low pH. Figure [2](#Fig2){ref-type="fig"}, called alkaline adsorption (Ak), is based on the analyses of the aliquots taken after the second incubation conducted at alkaline pH. Both, Ac and Ak, are calculated in percentage to the positive control (toxins without any adsorbent).

![Structural formula of deoxynivalenol.](11046_2007_Article_93_Fig1){#Fig1}

![Structural formula of zearalenone.](11046_2007_Article_93_Fig2){#Fig2}

Results {#Sec10}
=======

In order to assess the mycotoxin binding capacity of the adsorbents, an *in vitro* system designed to mimic the temperature, pH and passage time through the stomach and the gut of a monogastric animal was applied. The DON and ZON adsorption after the acidic (Ac) and the alkaline (Ak) phases was assessed chemically (HPLC analysis) or biologically (cell assays) of the remaining, nonabsorbed mycotoxin in the filtered aliquot.

DON adsorption {#Sec11}
--------------

DON (1 ppm) adsorption was assessed by HPLC analysis of the unbound fraction in the filtrate of the incubation mixture. In addition, the same filtrate was applied in a standard cytotoxicity assay with NIH/3T3-LNCX cells. Aliquots from poor binders (high concentration of unbound DON) reduce the cell viability, whereas those from potent binders did not. DON adsorption (Ac and Ak) exhibited by the mineral clays, humic substances and yeast-derived products tested at a concentration of 5 mg/ml are presented in Table [3](#Tab3){ref-type="table"}. The positive control, activated charcoal, was found to bind approximately 90% of DON in both assays. In contrast, all other products exerted a rather low DON adsorption, which was not significantly different from control incubation without any binder, neither following HPLC analysis nor according to the results of the bioassay. This implies that most of the substances had an Ac and Ak lower than 10%. Mineral1 and Humic5 achieved the highest Ak, which reached 21% (HPLC determination). The mineral and yeast products tended to exhibit higher Ak values as compared to the Ac values. These differences between Ac and Ak, however, were not significant (*p* \< 0.050) as for all the other tested products. The adsorption capacity of these products decreased when tested at a higher toxin concentration of 2.5 mg/ml (data not shown). The individual DON adsorption values obtained for the commercial 'mycotoxin binders' tested at a concentration of 2.5 mg binder per ml, which resembles the recommended concentrations to be used in feeds, are presented in Table [4](#Tab4){ref-type="table"}. The obtained values were also very low (\< 15%) for all the investigated products. Table 3*In vitro* percentage adsorption of DON by different mineral clays, humic substances and yeast cell-wall derived products as assessed by chemical and biological methods\*Product^a^HPLC^b^BIOASSAY^c^AcAkAcAkMineral18±721±115±311±8Mineral29±89±1015±510±3Mineral35±69±1410±415±11Humic15±79±119±76±5Humic25±1011±174±918±7Humic310±510±173±85±1Humic48±43±35±24±3Humic513±421±19±917±5Humic610±3011±108±76Yeast 11±15±710±1110±6Yeast 23±612±138±79±6Yeast 38±516±136±1015±7Yeast 411±715±1913±919±11Charcoal88±793±870±680±10\*Values are means ± SD of three independent experiments.Ac = acidic adsorption. Ak = alkaline adsorption.^a^All products were included at a concentrations of 5 mg/ml;^b^Detection limit: 0.05 mg/l;^c^Cytotoxicity Bioassay.Table 4*In vitro* percentage adsorption of DON and ZON by different mineral clays, humic substances and yeast cell wall derived products as assessed by chemical and biological methods\*Product^a^DONZONHPLC^b^Bioassay^c^HPLC^d^Bioassay^e^AcAkAcAkAcAkAcAkProduct18±89±65±34±817±735±730±1040±12Product24±45±102±33±338±832±851±1324±16Product37±1012±95±34±340±823±560±1434±11Product411±1518±86±510±325±511±839±1233±15Product513±1512±510±512±62±41±236± 1350± 15Product67±810±1111±613±897±099±098±297±2Charcoal88±793±870±680±1093±8100100100\*Values are means±SD of three independent experiments.Ac = acidic adsorption.Ak = alkaline adsorption.^a^All products were included at a concentrations of 2.5 mg/ml;^b^Detection limit: 0.05 mg/l;^c^Cytotoxicity bioassay;^d^Detection limit: 0.04 mg/l;^e^ Cell Proliferation bioassay.

ZON adsorption {#Sec12}
--------------

ZON adsorption was assessed by HPLC analysis of the unbound fraction in the incubation filtrates from 3 individual experiments with varying concentrations of the binder of 5 mg/mg, 2.5 mg/ml and 1 mg/ml, respectively. The incubations conducted with 2.5 mg/ml adsorbent where in parallel assessed in a bioassay with MCF-7 cells, assessing the estrogenic activity of the unbound toxin fraction. Table [5](#Tab5){ref-type="table"} presents the results of ZON adsorption (Ac and Ak) exhibited by the smectites, humic acids and yeast cell wall materials. The reference material, activated charcoal, exhibited a near to 100% adsorption of ZON at all concentrations tested. The most effective compound (Ak and Ac \> 70% at an inclusion rate of 2.5 mg/ml) was Mineral1, followed by Humic1, Humic2, Humic4 and Yeast3. The other binding materials had Ac and Ak values that were considerably lower. For various products, notable differences were observed between individual Ac values and the corresponding AK values, for example for the compounds Mineral3, Humic3, Humic5 and Yeast3. These differences suggest the existence of an optimal concentrations of the binder and may serve a guidance for forthcoming *in vivo* studies Yeast4 showed a negligible adsorption rate when assessed by HPLC analysis but, surprisingly, appeared to exert a quite considerably decrease in estrogenic activity (Ac = 30% and Ak = 69%) when tested in the bioassay. The results obtained with the commercial products are presented in Table [4](#Tab4){ref-type="table"}. These products were tested only at an inclusion rate of 2.5 mg/ml, which corresponds to the concentration recommended by the distributing commercial companies. The best product here was Product6 exhibited a binding activity of \> 97% for Ac and Ak in both assays. Table 5*In vitro* percentage adsorption of ZON by different mineral clays, humic substances and yeast cell-wall derived products as assessed by chemical and biological methods\*Product^a^5 mg/ml2.5 mg/ml1 mg/mlHPLC^b^HPLCBIOASSAY^c^HPLCAcAkAcAkAcAkAcAkMineral192±388±671±974±283±274±363±1043±1Mineral236±46±118±74±75±61±27±92±2Mineral347±1115±118±74±725±157±1413±55±4Humic188±267±369±768±1066±256±561±357±9Humic290±188±469±1365±1278±1578±1368±261±5Humic348±916±538±213±1133±1521±1722±517±1Humic498±895±294±392±187±1090±1156±1147±15Humic59±838±157±815±115±617±610±1217±3Humic69±86±122±414±211±820±44±47±13Yeast 171±568±655±848±168±852±1246±2330±5Yeast 267±159±750±739±458±1339±1539±1127±5Yeast 388±577±169±1155±485±1672±1163±733±9Yeast 43±46±502±330± 1369± 1704±5Charcoal10010099±110010010097±198±2\*Values are means±SD of three independent experiments.Ac = acidic adsorption.Alkaline = alkaline adsorption.^a^All products included at the three indicated concentrations: 5, 2.5 and 1 mg/ml;^b^ Detection limit: 0.04mg/l;^c^Cell Proliferation Bioassay.

Discussion {#Sec13}
==========

Supplementing animal feeds with non-nutritive adsorbents has proven to substantially reduce the detrimental effects of AFB~1~ in farm animals \[[@CR45]\] and the carry-over of AFB~1~ in milk \[[@CR13]\]. Subsequently, various compounds have been tested for their potential to bind and sequester DON and ZON. However, efficient binders of AFB~1~ often do not adsorb DON or ZON to any appreciable degree due to the entirely different chemical structure of these Fusario-toxins. Therefore, various attempts have been made to identify new compounds, which efficiently bind DON and/or ZON. For the rapid screening of such new substance, a protocol for *in vitro* incubations at different pH level is presented, including chemical analysis of the unbound fraction, as well as cell-based bioassays. Comparable *in vitro* system consisted of a simple incubation series at different pH values according to the changes of the pH along the gastro-intestinal tract of pigs have been used before \[[@CR18], [@CR46]\] and were sometime completed by the addition of enzymes and bile fluid, to more closely resemble the conditions in the gastro-intestinal tract \[[@CR22]\]. In these assays, the binding capacity of a given compound is usually measured by chemical analysis of the unbound toxin fraction that remains in the aqueous phase. We used a comparable experimental design for the incubations at different pH values as present in the gastrointestinal tract of pigs to assess the binding affinity at an acidic as well as an alkaline pH, and added cell-based bioassays to the evaluation protocol. These biological assays are considered to be a valuable addition to the common chemical analysis of the unbound fraction, as they would detect unpredictable tenside-like activities of binders affecting the permeability of cell membranes and resulting in an increased cellular uptake and increase toxicity of the tested mycotoxins \[[@CR33]\]. Given the differences in the mechanism of action of the two selected toxins, DON activity was tested in a cytotoxicity assay, whereas the biological activity of ZEN was tested in a proliferation assay with estrogen-dependent MCF-7 cells. Both assays have been used previously to compare the effects of trichothecenes (including DON) and estrogenic compounds (including ZEN) \[[@CR42], [@CR47]\].

The smectites, humic acids and yeast cell wall materials were added to the buffer system at concentrations of 1, 2.5 and 5 mg/l, respectively, whereas the commercial binders were tested only at a concentration of 2.5 mg/ml. These concentrations were chosen in consideration of the common practice, where inclusions rates exceeding 5 kg per metric ton of feed are avoided as they would impair the caloric and nutritional value of feeds, due to dilution and unspecific binding of essential feed ingredients such as trace minerals and vitamins. The toxin concentrations used in the assays were set at 1 mg/l (corresponding to 1 ppm in feed) for DON and ZON, respectively. This toxin level is very common for DON in mixed feeds, whereas exposure to ZEA is often lower. However, as ZEA can be present in bulk feeds such as corn silage as well as in concentrates, the same concentration was used in the described model experiments.

In this complex model new candidate binders, such as humic compounds, and previously used compounds were compared. According to our results, none of the tested products, except activated charcoal (which was included as positive control), appears to bind DON efficiently. In contrast, one mineral clay, three humic substances and one yeast-derived product showed considerably high ZON adsorption, which makes the products candidates for further testing.

The results of the bioassay suggest a low toxicity of all binders tested, as no cytotoxicty was observed in the control incubations without the toxins. Moreover, the results of the bioassay exclude significant changes in the cellular uptake of the toxins, or possible mycotoxin-binder complexes. However, it should be mentioned that the latter possibility can not be entirely excluded, as only the overall reduction of the biological effects was measured, but not the actual intra-cellular concentration of the toxin. This would be only possible when radio-labelled toxins are used in the experiments. With one new compound, Yeast4, a considerable difference was found between the chemical and the biological assay. This product contains small-size purified manno-proteins, which may bind to ZON, but bypass the filtration. This would imply that the binding affinity of this product is underestimated in chemical analytical techniques that measure only the free, non-bound toxin fraction.

The comparison of all obtained results indicates that various compounds are effective in adsorbing ZEN, whereas none of the test compounds or commercial products was able to bind DON to an appreciable degree. These differences might be associated with typical characteristics in the chemical structures of the tested mycotoxins, as ZON exhibits a certain polarity in the -O-CO- group, whereas DON lacks any comparable polar group. The presented results also show that within the tested classes of compounds such as smectite clays, humic substances and yeast-wall derived products, individual difference in the ability to adsorb ZON exist, demanding that only individual compounds and not classes of molecules can be tested, as long as the specific physico-chemical properties essential for the binding of ZON are elucidated.

An interesting finding is the good binding capacity of humic substances. As already mentioned in the introduction, polymeric humic substances contain various binding sites, and have been introduced into human medicine as compounds to reduce the absorption and systemic availability of bacterial endotoxins \[[@CR48]--[@CR50]\]. This latter effect would be highly beneficial in the protection of pig health as well, and hence these compounds deserve further *in vivo* testing.

A number of relevant factors occurring *in vivo*, such as interactions of toxins with feed components and the effect of digestive enzymes, which may cleave again the formed complexes between binders and toxins, are not reflected in the presented *in vitro* model. The obvious advantage of *in vitro* models, however, is the possibility to rapidly screen the effect of high numbers of different substances, enabling a pre-selection of products. Moreover, *in vitro* testing of the incubation media by means of bioassays will identify possible toxic reaction products (formed between binders and toxins) as well as significant toxic effects of the binders as such. In needs to be stressed, however, that any potential mycotoxin binders should be thoroughly assessed in *in vivo* experiments to demonstrate the capability in reducing mycotoxicosis in farm animals under field conditions.

The authors gratefully acknowledge SANLUC International NV (Melle, Belgium) for their financial support. They also would like to thank Roel Maas-Bakker for the stimulating discussions.
